Stephen R. Marder

Psychiatry

300 Medical Plz
Los Angeles, CA 90095

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 148 publications

Characterizing the Impacts of Psychosis on Methamphetamine Use Patterns Among Individuals with Methamphetamine-Associated Psychosis.

Characterizing the Impacts of Psychosis on Methamphetamine Use Patterns Among Individuals with Methamphetamine-Associated Psychosis.

Journal: Substance use & addiction journal

Published: August 13, 2026

Toward a Pluralistic Model for the Schizophrenia Spectrum-Dopamine and Beyond.

Toward a Pluralistic Model for the Schizophrenia Spectrum-Dopamine and Beyond.

Journal: JAMA psychiatry

Published: July 08, 2026

Contemporary Clinicians and Researchers Need to Recognize Akathisia.

Contemporary Clinicians and Researchers Need to Recognize Akathisia.

Journal: Journal of clinical psychopharmacology

Published: March 17, 2026

Finding a Medication for Negative Symptoms in Schizophrenia: Why So Many Failures?

Finding a Medication for Negative Symptoms in Schizophrenia: Why So Many Failures?

Journal: The American journal of psychiatry

Published: March 01, 2026

The NLRP3 inflammasome: pathophysiology and therapeutic implications for schizophrenia and neuropsychiatric disorders.

The NLRP3 inflammasome: pathophysiology and therapeutic implications for schizophrenia and neuropsychiatric disorders.

Journal: Molecular psychiatry

Published: February 17, 2026

Rethinking Antipsychotic Comparisons: The Role of Prior Exposure and Tolerability.

Rethinking Antipsychotic Comparisons: The Role of Prior Exposure and Tolerability.

Journal: The American journal of psychiatry

Published: February 01, 2026

Psychosocial Interventions and Functional Recovery in Schizophrenia-Realizing Opportunities Today.

Psychosocial Interventions and Functional Recovery in Schizophrenia-Realizing Opportunities Today.

Journal: The Journal of clinical psychiatry

Published: December 17, 2025

Low incidence of extrapyramidal symptoms following treatment with a muscarinic agonist medication for schizophrenia.

Low incidence of extrapyramidal symptoms following treatment with a muscarinic agonist medication for schizophrenia.

Journal: Schizophrenia research

Published: December 03, 2025

Dopamine-Blocking Antipsychotics-Time for a New Conversation With Patients?

Dopamine-Blocking Antipsychotics-Time for a New Conversation With Patients?

Journal: JAMA psychiatry

Published: November 26, 2025

Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them.

Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them.

Journal: The American journal of psychiatry

Published: October 08, 2025

Withania somnifera (Ashwagandha) as an Adjunctive Treatment to Antipsychotic Medications for Patients With Schizophrenia.

Withania somnifera (Ashwagandha) as an Adjunctive Treatment to Antipsychotic Medications for Patients With Schizophrenia.

Journal: Journal of clinical psychopharmacology

Published: September 14, 2025

Efficacy and safety of iclepertin for cognitive impairment associated with schizophrenia (CONNEX programme): results from three phase 3 randomised controlled trials.

Efficacy and safety of iclepertin for cognitive impairment associated with schizophrenia (CONNEX programme): results from three phase 3 randomised controlled trials.

Journal: The lancet. Psychiatry

Published: June 11, 2025

Showing 1-12 of 148

Last Updated: 09/26/2026